Is atrial fibrillation associated with poor outcome after thrombolysis?

被引:53
作者
Sanak, Daniel [1 ,2 ]
Herzig, Roman [1 ,2 ]
Kral, Michal [1 ,2 ]
Bartkova, Andrea [1 ,2 ]
Zapletalova, Jana [3 ]
Hutyra, Martin [2 ,4 ]
Skoloudik, David [1 ,2 ]
Vlachova, Ivanka [1 ,2 ]
Veverka, Tomas [1 ,2 ]
Horak, David [2 ,5 ]
Kanovsky, Petr [1 ,2 ]
机构
[1] Palacky Univ, Dept Neurol, Stroke Ctr, Sch Med, Olomouc 77520, Czech Republic
[2] Univ Hosp, Olomouc 77520, Czech Republic
[3] Palacky Univ, Sch Med, Dept Biometry & Stat, Olomouc 77520, Czech Republic
[4] Palacky Univ, Sch Med, Dept Cardiol, Olomouc 77520, Czech Republic
[5] Palacky Univ, Sch Med, Dept Radiol, Olomouc 77520, Czech Republic
关键词
Ischemic stroke; Atrial fibrillation; Intravenous thrombolysis; MRI; Clinical outcome; ACUTE ISCHEMIC-STROKE; TISSUE-PLASMINOGEN ACTIVATOR; CEREBRAL-ARTERY OCCLUSION; IV-T-PA; HEART-FAILURE; COLLATERAL FLOW; RISK-FACTORS; RECANALIZATION; MANAGEMENT; INFARCTION;
D O I
10.1007/s00415-010-5452-4
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Atrial fibrillation (AF) is considered a predictor for severe stroke and poor outcome. The aim was to evaluate whether AF is associated with poor outcome in acute ischemic stroke (IS) patients treated with intravenous thrombolysis (IVT). In a retrospective study, 157 consecutive IS patients (98 males, mean age 67.3 +/- A 10.2 years), treated with IVT within 3 hours from stroke onset, were divided into two groups according to presence/absence of AF. Neurological deficit was evaluated using the NIHSS on admission, 24 hours, and 7 days later, while the 90-day clinical outcome was assessed using the modified Rankin Scale (mRS). A total of 66 patients (38 males) presented with AF. The baseline NIHSS was 13.3 +/- A 5.4 in AF and 11.0 +/- A 5.1 points in non-AF patients (P = 0.006). AF patients had arterial occlusions more frequently in the baseline MRA (54.5% in AF versus 25.3% in non-AF, P = 0.0002). No differences were found between groups in clinical improvement after 24 hours and 7 days or in rate of achieved recanalizations. AF patients had significantly poorer 90-day clinical outcome than non-AF patients (median mRS 2.5 vs. 1.0). Patients with AF had significantly worse 90-day clinical outcome after IVT compared to those without AF, probably due to more severe baseline neurological deficits and the greater number of arterial occlusions in the MRA before IVT.
引用
收藏
页码:999 / 1003
页数:5
相关论文
共 28 条
[1]   Impact of collateral flow on tissue fate in acute ischaemic stroke [J].
Bang, O. Y. ;
Saver, J. L. ;
Buck, B. H. ;
Alger, J. R. ;
Starkman, S. ;
Ovbiagele, B. ;
Kim, D. ;
Jahan, R. ;
Duckwiler, G. R. ;
Yoon, S. R. ;
Vinuela, F. ;
Liebeskind, D. S. .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2008, 79 (06) :625-629
[2]   Predicting major neurological improvement with intravenous recombinant tissue plasminogen activator treatment of stroke [J].
Brown, DL ;
Johnston, KC ;
Wagner, DP ;
Haley, EC .
STROKE, 2004, 35 (01) :147-150
[3]  
Christoforidis GA, 2005, AM J NEURORADIOL, V26, P1789
[4]   Timing of recanalization after tissue plasminogen activator therapy determined by transcranial Doppler correlates with clinical recovery from ischemic stroke [J].
Christou, I ;
Alexandrov, AV ;
Burgin, WS ;
Wojner, AW ;
Felberg, RA ;
Malkoff, M ;
Grotta, JC .
STROKE, 2000, 31 (08) :1812-1816
[5]   Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: A retrospective analysis of the SOLVD trials [J].
Dries, DL ;
Exner, DV ;
Gersh, BJ ;
Domanski, MJ ;
Waclawiw, MA ;
Stevenson, LW .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (03) :695-703
[6]   PREVALENCE, AGE DISTRIBUTION, AND GENDER OF PATIENTS WITH ATRIAL-FIBRILLATION - ANALYSIS AND IMPLICATIONS [J].
FEINBERG, WM ;
BLACKSHEAR, JL ;
LAUPACIS, A ;
KRONMAL, R ;
HART, RG .
ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (05) :469-473
[7]   Early dramatic recovery during intravenous tissue plasminogen activator infusion - Clinical pattern and outcome in acute middle cerebral artery stroke [J].
Felberg, RA ;
Okon, NJ ;
El-Mitwalli, A ;
Burgin, WS ;
Grotta, JC ;
Alexandrov, AV .
STROKE, 2002, 33 (05) :1301-1307
[8]   Predicting prognosis after stroke - A placebo group analysis from the National Institute of Neurological Disorders and Stroke rt-PA Stroke Trial [J].
Frankel, MR ;
Morgenstern, LB ;
Kwiatkowski, T ;
Lu, M ;
Tilley, BC ;
Broderick, JP ;
Libman, R ;
Levine, SR ;
Brott, T .
NEUROLOGY, 2000, 55 (07) :952-959
[9]   European Stroke Initiative Recommendations for Stroke Management - Update 2003 [J].
Hacke, W .
CEREBROVASCULAR DISEASES, 2003, 16 (04) :311-337
[10]   Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II) [J].
Hacke, W ;
Kaste, M ;
Fieschi, C ;
von Kummer, R ;
Davalos, A ;
Meier, D ;
Larrue, V ;
Bluhmki, E ;
Davis, S ;
Donnan, G ;
Schneider, D ;
Diez-Tejedor, E ;
Trouillas, P .
LANCET, 1998, 352 (9136) :1245-1251